Olivier Saulnier

16PUBLICATIONS
136CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 02, 2026
Publisher Correction: An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate.

Jamie Zagozewski, Ghazaleh M Shahriary, Ludivine Coudière Morrison

|Jul 25, 2025
Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy.

Cory M Richman, Alexandra Rasnitsyn, Borja L Holgado

|Sep 04, 2024
Insights on Future Directions in Cancer Research from the AACR NextGen Stars.

Israel Cañadas, Gabriele Casirati, Kathleen E Houlahan

|Jul 18, 2024
A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing.

Olivier Saulnier, Jamie Zagozewski, Lisa Liang

Pageof 3